Eclipse Regenesis Grant Offers Hope to SBS Sufferers

Eclipse Regenesis, Inc., has developed the first restorative therapy to address pediatric and adult Short Bowel Syndrome. The company has now been awarded a National Institutes of Health (NIH) Small Business Innovation Research (NIH SBIR) Fast Track grant of $1.7 million. These funds will be used...